(Q40046565)

16 September 2017

1 reference

title

Primary malignant tumors of bone. Evaluation of current diagnosis and treatment (English)

1 reference

16 September 2017

Primary malignant tumors of bone.Evaluation of current diagnosis and treatment (English)

1 reference

10.1002/1097-0142(1967)20:5<738::AID-CNCR2820200527>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(1967)20:5%3C738::AID-CNCR2820200527%3E3.0.CO;2-1

3 May 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5337394

3 May 2023

1 reference

10.1002/1097-0142(1967)20:5<738::AID-CNCR2820200527>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(1967)20:5%3C738::AID-CNCR2820200527%3E3.0.CO;2-1

3 May 2023

author name string

M. M. Copeland

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5337394

3 May 2023

language of work or name

English

0 references

publication date

1 May 1967

1 reference

full work available at URL

16 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(1967)20:5%3C738::AID-CNCR2820200527%3E3.0.CO;2-1

1 reference

10.1002/1097-0142(1967)20:5<738::AID-CNCR2820200527>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(1967)20:5%3C738::AID-CNCR2820200527%3E3.0.CO;2-1

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(1967)20:5%3C738::AID-CNCR2820200527%3E3.0.CO;2-1

3 May 2023

1 reference

10.1002/1097-0142(1967)20:5<738::AID-CNCR2820200527>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(1967)20:5%3C738::AID-CNCR2820200527%3E3.0.CO;2-1

3 May 2023

1 reference

16 September 2017

volume

20

1 reference

16 September 2017

issue

5

1 reference

16 September 2017

page(s)

738-746

1 reference

Treatment of multiple myeloma with urethan; experience with 66 cases over a 2 1/2 year period.

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%281967%2920%3A5%3C738%3A%3AAID-CNCR2820200527%3E3.0.CO%3B2-1

MYELOMA PROTEINS AND THE CLINICAL RESPONSE TO MELPHALAN THERAPY

21 January 2018

5

1 reference

10.1002/1097-0142(1967)20:5<738::AID-CNCR2820200527>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(1967)20:5%3C738::AID-CNCR2820200527%3E3.0.CO;2-1

Primary reticulum-cell sarcoma of bone; summary of 37 cases

3 May 2023

9

1 reference

10.1002/1097-0142(1967)20:5<738::AID-CNCR2820200527>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(1967)20:5%3C738::AID-CNCR2820200527%3E3.0.CO;2-1

3 May 2023

11

129

724

Copeland

1949

1 reference

10.1002/1097-0142(1967)20:5<738::AID-CNCR2820200527>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(1967)20:5%3C738::AID-CNCR2820200527%3E3.0.CO;2-1

The palliative care of inoperable and incurable recrudescent neoplasms

3 May 2023

12

1 reference

10.1002/1097-0142(1967)20:5<738::AID-CNCR2820200527>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(1967)20:5%3C738::AID-CNCR2820200527%3E3.0.CO;2-1

Parosteal osteoma of bone: a new entity

3 May 2023

19

1 reference

10.1002/1097-0142(1967)20:5<738::AID-CNCR2820200527>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(1967)20:5%3C738::AID-CNCR2820200527%3E3.0.CO;2-1

Agents used in cancer chemotherapy

3 May 2023

20

1 reference

10.1002/1097-0142(1967)20:5<738::AID-CNCR2820200527>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(1967)20:5%3C738::AID-CNCR2820200527%3E3.0.CO;2-1

Benign and malignant giant cell tumors of bone.A clinicopathological analysis of the natural history of the disease

3 May 2023

21

1 reference

10.1002/1097-0142(1967)20:5<738::AID-CNCR2820200527>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(1967)20:5%3C738::AID-CNCR2820200527%3E3.0.CO;2-1

Cyclophosphamide in children with cancer

3 May 2023

31

1 reference

10.1002/1097-0142(1967)20:5<738::AID-CNCR2820200527>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(1967)20:5%3C738::AID-CNCR2820200527%3E3.0.CO;2-1

The therapy of sarcomas by isolation perfusion

3 May 2023

32

1 reference

10.1002/1097-0142(1967)20:5<738::AID-CNCR2820200527>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(1967)20:5%3C738::AID-CNCR2820200527%3E3.0.CO;2-1

L-PHENYLALANINE MUSTARD AS A TREATMENT FOR METASTATIC OSTEOGENIC SARCOMA IN CHILDREN

3 May 2023

37

1 reference

10.1002/1097-0142(1967)20:5<738::AID-CNCR2820200527>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(1967)20:5%3C738::AID-CNCR2820200527%3E3.0.CO;2-1

The place of external irradiation in the treatment of osteogenic sarcoma

3 May 2023

38

1 reference

10.1002/1097-0142(1967)20:5<738::AID-CNCR2820200527>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(1967)20:5%3C738::AID-CNCR2820200527%3E3.0.CO;2-1

3 May 2023

Identifiers

10.1002/1097-0142(1967)20:5<738::AID-CNCR2820200527>3.0.CO;2-1

1 reference

16 September 2017

1 reference